Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese.
Okuno T, Tamura T, Yamamori M, Chayahara N, Yamada T, Miki I, Okamura N, Kadowaki Y, Shirasaka D, Aoyama N, Nakamura T, Okumura K, Azuma T, Kasuga M, Sakaeda T. Okuno T, et al. Among authors: sakaeda t. Am J Clin Oncol. 2007 Jun;30(3):252-7. doi: 10.1097/01.coc.0000256059.88247.25. Am J Clin Oncol. 2007. PMID: 17551301
Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer.
Chayahara N, Tamura T, Yamamori M, Kadowaki Y, Okuno T, Miki I, Tsuda M, Nishisaki H, Maeda T, Inoue Y, Okumura K, Azuma T, Kasuga M, Sakaeda T, Hirai M. Chayahara N, et al. Among authors: sakaeda t. Am J Clin Oncol. 2009 Feb;32(1):56-60. doi: 10.1097/COC.0b013e31817c6a68. Am J Clin Oncol. 2009. PMID: 19194126 Clinical Trial.
Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A, Yamamori M, Nishiguchi K, Okuno T, Chayahara N, Miki I, Tamura T, Inokuma T, Takemoto Y, Nakamura T, Kataoka K, Sakaeda T. Kuwahara A, et al. Among authors: sakaeda t. Int J Med Sci. 2009 Sep 28;6(6):305-11. doi: 10.7150/ijms.6.305. Int J Med Sci. 2009. PMID: 19834547 Free PMC article.
Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma.
Kuwahara A, Yamamori M, Nishiguchi K, Okuno T, Chayahara N, Miki I, Tamura T, Kadoyama K, Inokuma T, Takemoto Y, Nakamura T, Kataoka K, Sakaeda T. Kuwahara A, et al. Among authors: sakaeda t. Int J Med Sci. 2010 Jan 31;7(1):48-54. doi: 10.7150/ijms.7.48. Int J Med Sci. 2010. PMID: 20151048 Free PMC article. Clinical Trial.
TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A, Yamamori M, Fujita M, Okuno T, Tamura T, Kadoyama K, Okamura N, Nakamura T, Sakaeda T. Kuwahara A, et al. Among authors: sakaeda t. J Exp Clin Cancer Res. 2010 Jul 20;29(1):100. doi: 10.1186/1756-9966-29-100. J Exp Clin Cancer Res. 2010. PMID: 20646319 Free PMC article.
Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A, Yamamori M, Kadoyama K, Nishiguchi K, Nakamura T, Miki I, Tamura T, Okuno T, Omatsu H, Sakaeda T. Kuwahara A, et al. Among authors: sakaeda t. J Exp Clin Cancer Res. 2011 Oct 5;30(1):94. doi: 10.1186/1756-9966-30-94. J Exp Clin Cancer Res. 2011. PMID: 21970688 Free PMC article.
207 results